Compound in-cis JAK2 mutant polycythemia vera manifesting as first-onset transient ischemic attack with erythrocytosis and an attenuated JAK2 V617F mutant signal on a quantitative DD-PCR assay

Int J Lab Hematol. 2023 Apr;45(2):e28-e31. doi: 10.1111/ijlh.13979. Epub 2022 Oct 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Ischemic Attack, Transient* / etiology
  • Ischemic Attack, Transient* / genetics
  • Janus Kinase 2* / genetics
  • Mutation
  • Polycythemia Vera* / complications
  • Polycythemia Vera* / diagnosis
  • Polycythemia Vera* / genetics
  • Polycythemia* / diagnosis
  • Polycythemia* / etiology
  • Polycythemia* / genetics
  • Polymerase Chain Reaction

Substances

  • JAK2 protein, human
  • Janus Kinase 2